These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 25589163

  • 21. Distinctive patterns of PDGF-A, FGF-2, IGF-I, and TGF-beta1 gene expression during remyelination of experimentally-induced spinal cord demyelination.
    Hinks GL, Franklin RJ.
    Mol Cell Neurosci; 1999 Aug; 14(2):153-68. PubMed ID: 10532806
    [Abstract] [Full Text] [Related]

  • 22. Increased mitochondrial content in remyelinated axons: implications for multiple sclerosis.
    Zambonin JL, Zhao C, Ohno N, Campbell GR, Engeham S, Ziabreva I, Schwarz N, Lee SE, Frischer JM, Turnbull DM, Trapp BD, Lassmann H, Franklin RJ, Mahad DJ.
    Brain; 2011 Jul; 134(Pt 7):1901-13. PubMed ID: 21705418
    [Abstract] [Full Text] [Related]

  • 23. Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells.
    Mi S, Miller RH, Tang W, Lee X, Hu B, Wu W, Zhang Y, Shields CB, Zhang Y, Miklasz S, Shea D, Mason J, Franklin RJ, Ji B, Shao Z, Chédotal A, Bernard F, Roulois A, Xu J, Jung V, Pepinsky B.
    Ann Neurol; 2009 Mar; 65(3):304-15. PubMed ID: 19334062
    [Abstract] [Full Text] [Related]

  • 24. Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS.
    Fancy SP, Baranzini SE, Zhao C, Yuk DI, Irvine KA, Kaing S, Sanai N, Franklin RJ, Rowitch DH.
    Genes Dev; 2009 Jul 01; 23(13):1571-85. PubMed ID: 19515974
    [Abstract] [Full Text] [Related]

  • 25. A higher proportion of ermin-immunopositive oligodendrocytes in areas of remyelination.
    Ahmad I, Wergeland S, Oveland E, Bø L.
    PLoS One; 2021 Jul 01; 16(8):e0256155. PubMed ID: 34437581
    [Abstract] [Full Text] [Related]

  • 26. Schwann Cell Remyelination in the Multiple Sclerosis Central Nervous System.
    Ghezzi L, Bollman B, De Feo L, Piccio L, Trapp BD, Schmidt RE, Cross AH.
    Lab Invest; 2023 Jun 01; 103(6):100128. PubMed ID: 36889543
    [Abstract] [Full Text] [Related]

  • 27. Remyelination in multiple sclerosis.
    Chari DM.
    Int Rev Neurobiol; 2007 Jun 01; 79():589-620. PubMed ID: 17531860
    [Abstract] [Full Text] [Related]

  • 28. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches.
    Olsen JA, Akirav EM.
    J Neurosci Res; 2015 May 01; 93(5):687-96. PubMed ID: 25287108
    [Abstract] [Full Text] [Related]

  • 29. Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance.
    Barkhof F, Bruck W, De Groot CJ, Bergers E, Hulshof S, Geurts J, Polman CH, van der Valk P.
    Arch Neurol; 2003 Aug 01; 60(8):1073-81. PubMed ID: 12925362
    [Abstract] [Full Text] [Related]

  • 30. Notch1 and Jagged1 are expressed after CNS demyelination, but are not a major rate-determining factor during remyelination.
    Stidworthy MF, Genoud S, Li WW, Leone DP, Mantei N, Suter U, Franklin RJ.
    Brain; 2004 Sep 01; 127(Pt 9):1928-41. PubMed ID: 15289265
    [Abstract] [Full Text] [Related]

  • 31. Demyelination versus remyelination in progressive multiple sclerosis.
    Bramow S, Frischer JM, Lassmann H, Koch-Henriksen N, Lucchinetti CF, Sørensen PS, Laursen H.
    Brain; 2010 Oct 01; 133(10):2983-98. PubMed ID: 20855416
    [Abstract] [Full Text] [Related]

  • 32. Fibroblast growth factor 2 (FGF2) and FGF receptor expression in an experimental demyelinating disease with extensive remyelination.
    Messersmith DJ, Murtie JC, Le TQ, Frost EE, Armstrong RC.
    J Neurosci Res; 2000 Oct 15; 62(2):241-56. PubMed ID: 11020217
    [Abstract] [Full Text] [Related]

  • 33. Inactivation of sphingosine-1-phosphate receptor 2 (S1PR2) decreases demyelination and enhances remyelination in animal models of multiple sclerosis.
    Seyedsadr MS, Weinmann O, Amorim A, Ineichen BV, Egger M, Mirnajafi-Zadeh J, Becher B, Javan M, Schwab ME.
    Neurobiol Dis; 2019 Apr 15; 124():189-201. PubMed ID: 30468865
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination.
    Mullin AP, Cui C, Wang Y, Wang J, Troy E, Caggiano AO, Parry TJ, Colburn RW, Pavlopoulos E.
    Neurobiol Dis; 2017 Sep 15; 105():142-155. PubMed ID: 28576706
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Migration and remyelination by oligodendrocyte progenitor cells transplanted adjacent to focal areas of spinal cord inflammation.
    Wang Y, Piao JH, Larsen EC, Kondo Y, Duncan ID.
    J Neurosci Res; 2011 Nov 15; 89(11):1737-46. PubMed ID: 21793039
    [Abstract] [Full Text] [Related]

  • 38. Multiple Sclerosis: Basic and Clinical.
    Buzzard K, Chan WH, Kilpatrick T, Murray S.
    Adv Neurobiol; 2017 Nov 15; 15():211-252. PubMed ID: 28674983
    [Abstract] [Full Text] [Related]

  • 39. Short-term treatment with interferon-alpha/beta promotes remyelination, whereas long-term treatment aggravates demyelination in a murine model of multiple sclerosis.
    Njenga MK, Coenen MJ, DeCuir N, Yeh HY, Rodriguez M.
    J Neurosci Res; 2000 Mar 01; 59(5):661-70. PubMed ID: 10686594
    [Abstract] [Full Text] [Related]

  • 40. Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination.
    McLane LE, Bourne JN, Evangelou AV, Khandker L, Macklin WB, Wood TL.
    J Neurosci; 2017 Aug 02; 37(31):7534-7546. PubMed ID: 28694334
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.